EGFR and non-small cell lung carcinoma: The risk score, sex, smoking history, EGFR mutation, TNM stage, and surgery treatment were significantly associated with OS in NSCLC patients receiving EGFR-TKI (Table 1), which were included in the construction of nomogram model for visually and personally predicting 1-, 2-, 3-, 4-, and 5-year OS rates (Fig. 3A).